Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

284 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
EULAR points to consider when analysing and reporting comparative effectiveness research using observational data in rheumatology.
Courvoisier DS, Lauper K, Kedra J, de Wit M, Fautrel B, Frisell T, Hyrich KL, Iannone F, Machado PM, Ørnbjerg LM, Rotar Z, Santos MJ, Stamm TA, Stones SR, Strangfeld A, Bergstra SA, Landewé RBM, Finckh A. Courvoisier DS, et al. Ann Rheum Dis. 2022 Jun;81(6):780-785. doi: 10.1136/annrheumdis-2021-221307. Epub 2022 Jan 20. Ann Rheum Dis. 2022. PMID: 35058229
Which subgroup of patients with rheumatoid arthritis benefits from switching to rituximab versus alternative anti-tumour necrosis factor (TNF) agents after previous failure of an anti-TNF agent?
Finckh A, Ciurea A, Brulhart L, Möller B, Walker UA, Courvoisier D, Kyburz D, Dudler J, Gabay C; Arthritis. Finckh A, et al. Ann Rheum Dis. 2010 Feb;69(2):387-93. doi: 10.1136/ard.2008.105064. Epub 2009 May 4. Ann Rheum Dis. 2010. PMID: 19416802 Free PMC article.
Pain as an important predictor of psychosocial health in patients with rheumatoid arthritis.
Courvoisier DS, Agoritsas T, Glauser J, Michaud K, Wolfe F, Cantoni E, Perneger TV, Finckh A; Swiss Clinical Quality Management Program for Rheumatoid Arthritis; National Data Bank for Rheumatic Diseases. Courvoisier DS, et al. Arthritis Care Res (Hoboken). 2012 Feb;64(2):190-6. doi: 10.1002/acr.20652. Arthritis Care Res (Hoboken). 2012. PMID: 21972106 Free article.
Brief Report: Association of Rheumatoid Factor and Anti-Citrullinated Protein Antibody Positivity With Better Effectiveness of Abatacept: Results From the Pan-European Registry Analysis.
Gottenberg JE, Courvoisier DS, Hernandez MV, Iannone F, Lie E, Canhão H, Pavelka K, Hetland ML, Turesson C, Mariette X, Finckh A. Gottenberg JE, et al. Among authors: courvoisier ds. Arthritis Rheumatol. 2016 Jun;68(6):1346-52. doi: 10.1002/art.39595. Arthritis Rheumatol. 2016. PMID: 26815727
Rheumatoid Arthritis Patients after Initiation of a New Biologic Agent: Trajectories of Disease Activity in a Large Multinational Cohort Study.
Courvoisier DS, Alpizar-Rodriguez D, Gottenberg JE, Hernandez MV, Iannone F, Lie E, Santos MJ, Pavelka K, Turesson C, Mariette X, Choquette D, Hetland ML, Finckh A. Courvoisier DS, et al. EBioMedicine. 2016 Sep;11:302-306. doi: 10.1016/j.ebiom.2016.08.024. Epub 2016 Aug 18. EBioMedicine. 2016. PMID: 27558858 Free PMC article.
Body mass does not impact the clinical response to intravenous abatacept in patients with rheumatoid arthritis. Analysis from the "pan-European registry collaboration for abatacept (PANABA).
Iannone F, Courvoisier DS, Gottenberg JE, Hernandez MV, Lie E, Canhão H, Pavelka K, Hetland ML, Turesson C, Mariette X, Choquette D, Finckh A. Iannone F, et al. Among authors: courvoisier ds. Clin Rheumatol. 2017 Apr;36(4):773-779. doi: 10.1007/s10067-016-3505-5. Epub 2016 Dec 14. Clin Rheumatol. 2017. PMID: 27966068
Lessons learned from rheumatoid arthritis registries.
Finckh A, Courvoisier D. Finckh A, et al. Joint Bone Spine. 2018 May;85(3):271-274. doi: 10.1016/j.jbspin.2017.12.005. Epub 2017 Dec 12. Joint Bone Spine. 2018. PMID: 29246533 Review. No abstract available.
Open-label, multicentre, dose-escalating phase II clinical trial on the safety and efficacy of tadekinig alfa (IL-18BP) in adult-onset Still's disease.
Gabay C, Fautrel B, Rech J, Spertini F, Feist E, Kötter I, Hachulla E, Morel J, Schaeverbeke T, Hamidou MA, Martin T, Hellmich B, Lamprecht P, Schulze-Koops H, Courvoisier DS, Sleight A, Schiffrin EJ. Gabay C, et al. Among authors: courvoisier ds. Ann Rheum Dis. 2018 Jun;77(6):840-847. doi: 10.1136/annrheumdis-2017-212608. Epub 2018 Feb 22. Ann Rheum Dis. 2018. PMID: 29472362 Free PMC article. Clinical Trial.
Comparative effectiveness of tocilizumab versus TNF inhibitors as monotherapy or in combination with conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis after the use of at least one biologic disease-modifying antirheumatic drug: analyses from the pan-European TOCERRA register collaboration.
Lauper K, Nordström DC, Pavelka K, Hernández MV, Kvien TK, Kristianslund EK, Santos MJ, Rotar Ž, Iannone F, Codreanu C, Lukina G, Gale SL, Sarsour K, Luder Y, Courvoisier DS, Gabay C. Lauper K, et al. Among authors: courvoisier ds. Ann Rheum Dis. 2018 Sep;77(9):1276-1282. doi: 10.1136/annrheumdis-2017-212845. Epub 2018 May 5. Ann Rheum Dis. 2018. PMID: 29730637
284 results